Introduction {#s1}
============

The number of patients diagnosed with major depressive disorder (MDD) has been increasing in recent years around the world and scientists predict that mood disorders induced by MDD will be the primary cause of mental disability by 2020 (Shinba, [@B10]; WHO, [@B15]). MDD has a variety of causes, including mental stress, which can lead neurogenic shock, cardiovascular diseases, neuropsychiatric diseases, gastrointestinal diseases, and increased suicidal intent (Selye, [@B9]; Kerr, [@B4]).

Diagnostic systems for a variety of diseases are continually being improved and broadened. For instance, we have developed various infection screening systems using infrared cameras and microwave radars (Matsui et al., [@B7], [@B8]; Sun et al., [@B12]; Yao et al., [@B16]). However, for people who might have MDD, going to psychiatric facilities with experienced doctors is laborious and stressful (Westen, [@B14]; Culpepper et al., [@B1]). Moreover, delaying the start of medical treatment can lead to exacerbated symptoms and greater daily disability. To overcome such incidents, we have developed an MDD screening method based on autonomic responses during a mental task, which combines heart rate variability (HRV) with logistic regression analysis. In our previous study, HRV was determined using electrocardiography (ECG). However, ECG measurement requires electrodes to be attached to a person\'s body, supervision of medical personnel, and inconveniences associated with any trips to a clinic or a hospital. To avoid such stressful and restrained screening for MDD, we have developed a novel MDD screening system that incorporates fingertip photoplethysmographic (PPG) sensor and logistic regression analysis (Figure [1](#F1){ref-type="fig"}).

![Main body of the novel screening system for major depressive disorder. The system uses a photoplethysmographic sensor to record response-based transient autonomic nerve activity.](fbioe-06-00064-g0001){#F1}

A system which does not require medical personal help for electrode attachment can enable MDD screening at home or at the work place. Here we report a clinical test of the proposed MDD screening system that included 6 patients with MDD and 14 healthy control participants. The method was evaluated via leave-one-out cross validation (LOOCV).

System design {#s2}
=============

Heart rate variability as a tool for transient autonomic response measurement
-----------------------------------------------------------------------------

In recent years, applicability of HRV power spectral analysis has gradually been extended from basic research to clinic practice, as evidenced by the large number of clinical studies that have been undertaken (Malik and Camm, [@B6]). Shinba reported that the HF component of the HRV, which corresponds to parasympathetic activation, differed between patients with MDD and healthy volunteers (Shinba, [@B10]). Compared with other techniques used to explore autonomic control, spectral analysis of HRV is unique because it provides an opportunity for a continuous examination of reciprocal changes in sympathetic and vagal modulation. According to HRV spectral analysis, most of the HRV signal power is concentrated in two frequency ranges: HF and LF. The HF band (0.15--0.4 Hz) is associated with parasympathetic activity and the LF band (0.04--0.15 Hz) is modulated by baroreflex-induced cardiac autonomic outflow (Goldstein et al., [@B3]). Based on these properties, our previous study confirmed that variance in HRV variables could be used as an MDD screening tool (Sun et al., [@B13]).

Hardware design of the proposed system
--------------------------------------

The exterior design of the proposed system is shown in Figure [1](#F1){ref-type="fig"}. A PPG sensor was mounted on a finger clipper to measure fingertip pulse (Figure [2A](#F2){ref-type="fig"}). We used a PPG sensor with a greenish yellow light (wave length: 565 nm; Avago-technologies APDS-9008) and a 1-MHz low-power operation amplifier (MCP-6001). The amplifier output is transferred to a personal computer at a sampling rate of 100 Hz through a 12-bit AD converter with a USB port (Figure [2B](#F2){ref-type="fig"}). A wireless connection with a smartphone can be utilized as a graphic terminal (Figure [2C](#F2){ref-type="fig"}).

![System configuration. **(A)** A photoplethysmographic sensor equipped finger clipper for pulse measurement. **(B)** USB connection to computer. **(C)** wireless connection to a smartphone.](fbioe-06-00064-g0002){#F2}

Software design of the proposed system
--------------------------------------

The sampling and analyzing software was written in LabView graphical block diagram programming language (National Instruments, Texas, USA). The time series of peak to peak (PP) PPG intervals are interpolated using a polynomial and resampled at 4 Hz. This procedure was included to achieve equally spaced sampling for Fast Fourier Transform (FFT) and was necessary because PP intervals fluctuate with autonomic nerves activity. The power spectrum of resampled PP intervals was calculated using FFT every 2 s for 30 s of data. The power spectrum was then integrated from 0.04 to 0.15 Hz to calculate the LF component of the HRV and from 0.15 to 0.4 Hz to determine the HF component of the HRV. The logit of the logistic regression analysis that discriminates patients with MDD from healthy volunteers is determined by:
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The logistic regression coefficient matrix, *A*~*ij*~ and a *constant* are determined by logistic regression variables which were the mean HR, HF, and LF/HF for each time period (before, during, and after the mental task) for both groups of participants via machine learning software WEKA 3.8.1. *Xj1, Xj2*, and *Xj3* represent HR, HF, and LF/HF, respectively. The suffix *j* represents the three periods (1 = before, 2 = during, 3 = after). To precisely estimate screening accuracy, we conducted LOOCV, which is the preferred technique when estimating accuracy with a small data set. LOOCV is a particular case of *k*-fold cross-validation, where *k* equals the number of total instances. Thus, in each iteration a single observation is withheld from training, other recent samples are used for training, and the model is tested on that single observation after training is completed.

Materials and methods {#s3}
=====================

Photoplethysmographic measurement
---------------------------------

Fingertip PPG signal reflects arterial blood pulsation, which is modulated by autonomically influenced cardiac pulsation (Lin et al., [@B5]). We positioned the PPG sensor on the middle phalanx of an index finger. As a reference, the data derived by the proposed system was compared with that derived from ECG, and we calculated the Pearson correlation coefficients between the HR and HRV indices that were derived from the two different methods.

Participants in the clinical test
---------------------------------

Six patients with MDD (4 females and 2 males, aged 23--60 years) who were taking antidepressant medication were recruited from the psychiatry outpatient unit of Shizuoka Saiseikai General Hospital. Fourteen healthy volunteers (6 females and 8 males, aged 21--63 years) were recruited from the University of Electro-Communications. All participants provided written informed consent.

Measurement protocol
--------------------

Participants sat on a chair and had placed their fingers in the finger clip for PPG measurement. They chose a display device (computer monitor or a smartphone) that provided visual instructions. PPG sensors started to recording the HRV signals when the instruction began and continued for 320 s during the three periods (Figure [3](#F3){ref-type="fig"}) before, during, and after the mental task. Before the mental task (100 s), participants sat still and relaxed. During the mental task (100 s) they vocalized a random number from 0 to 9 each second. After mental task (120 s) they relaxed again.

![Schematic diagram of the measurement procedure.](fbioe-06-00064-g0003){#F3}

Results {#s4}
=======

Figure [4](#F4){ref-type="fig"} shows the PPG and ECG amplitudes of a typical healthy volunteer for 4 s. The PPG peaked at approximately 300 ms after R wave was seen on the ECG. The PP intervals for PPG were almost the same as the RR intervals from the ECG.

![Amplitude over time, measured by ECG and PPG sensors.](fbioe-06-00064-g0004){#F4}

The HR, HF, and LF/HF determined by PPG significantly correlated with those calculated from ECG signals (HR; *r* = 1.0, *p* \< 0.0001, HF; *r* = 0.98, *p* \< 0.0001; LF/HF; *r* = 0.98, *p* \< 0.0001). As shown in Figure [5](#F5){ref-type="fig"}, PPG- and ECG-derived HR were exactly linearly correlated, while HF and LF/HF were slightly less correlated. This can be explained by small artifacts in the PP intervals that affect frequency domain parameters such as HF and LF/HF.

![Scatter plots for **(A)** HR, **(B)** HF, and **(C)** LF/HF values derived from ECG and PPG sensors.](fbioe-06-00064-g0005){#F5}

Figure [6](#F6){ref-type="fig"} shows the PPG- and ECG-derived HR, HF, and LF/HF values for a typical healthy volunteer and a patient with MDD during the experiment. The horizontal axis spans one before/during/after cycle of the task (320 s). The HR, HF and LF/HF values for the healthy volunteer showed a drastic change during the mental task. In contrast, the HR of the patient did not change during the mental task, while the HF and LF/HF showed a later response to the mental task than what was observed in the healthy volunteer. PPG- and ECG-derived HR and HF match fairly well, while the task-induced response in LF/HF determined by ECG was higher than that derived by PPG.

![HRV and HR values before (0--100 s), during (100--200 s), and after (200--320 s) a mental task. Signals on the right are from a healthy volunteer and signals on left are from a patient. **(A)** HR-value. **(B)** HF-value. **(C)** LF/HF-value.](fbioe-06-00064-g0006){#F6}

The logit score that distinguishes patients with MDD from healthy volunteers was calculated by Equation (1). The multiple logistic regression coefficients A~ij~ and corresponding logistic regression variables X~ji~ in Equation (1) are listed in Table [1](#T1){ref-type="table"}.

###### 

Logistic regression variables and corresponding multiple logistic regression coefficients.

  **Logistic regression variables**   **Corresponding multiple logistic regression coefficients**
  ----------------------------------- -------------------------------------------------------------
  HR Before MT(X~11~)                 0.23 (A~11~)
  HR During MT(X~21~)                 6.43 (A~12~)
  HR After MT(X~31~)                  −9.7 (A~13~)
  HF Before MT(X~12~)                 −4.97 (A~21~)
  HF During MT(X~22~)                 4.73 (A~22~)
  HF After MT(X~32~)                  −3.59 (A~23~)
  LF/HF Before MT(X~13~)              −36.78 (A~31~)
  LF/HF During MT(X~23~)              30.81 (A~32~)
  LF/HF After MT(X~33~)               −87.24 (A~33~)
                                      605.15 (constant)

Equation (1), i.e., linear combination of nine variables which determine logit score indicated statistical significance (*p* \< 0.01), and it achieved high screening sensitivity (83%) and specificity (93%) (Figure [7](#F7){ref-type="fig"}), although *F*-test and *t*-test (GraphPad Software) revealed that some variables are not statistically significant (HF~duringMT~, HF~afterMT~, LF/HF~beforeMT~, and LF/HF~duringMT~) as shown in Table [2](#T2){ref-type="table"}.

![Discrimination results represented by plotting the logit score.](fbioe-06-00064-g0007){#F7}

###### 

Paired *t*-test and *F*-test result between patients with MDD and healthy volunteers\' heart rates (HR) and heart rate variability (HRV) indices.

  **Variables**                    **HR(bpm)**                         **HF(ms**^**2**^**)**             **LF/HF**                                                                                                                                                         
  -------------------------------- ----------------------------------- --------------------------------- --------------------------------- --------------------------------- --------------- --------------- --------------- ----------- --------------------------------- ------------
  *p*-value                        0.01                                0.03                              0.02                              0.05                              0.17            0.11            0.42            0.32        0.03                              
  *F*-test value                   1.03                                1.11                              0.93                              0.33                              4.82            0.44            1.65            5.98        0.14                              
  Statistical significance level   [\*\*](#TN1){ref-type="table-fn"}   [\*](#TN2){ref-type="table-fn"}   [\*](#TN2){ref-type="table-fn"}   [\*](#TN2){ref-type="table-fn"}   *ns*            *ns*            *ns*            *ns*        [\*](#TN2){ref-type="table-fn"}   
  Mean ±*SD*                       MDD                                 84.7 ± 8.4                        87.9 ± 8                          82.2 ± 8.3                        56.4 ± 54.4     29.4 ± 21.3     62.8 ± 31.8     3.5 ± 1.3   6.6 ± 2.8                         4.6 ± 2.76
                                   Healthy                             73.8 ± 8.5                        77.8 ± 8.5                        70 ± 8.3                          365.9 ± 519.4   109.9 ± 170.8   334.4 ± 370.1   1.3 ± 2.5   5 ± 5.4                           ±1

Mean values with standard deviation (SD) of HR and HRV indices before, during and after mental task (MT). Statistical significance level:

very significant;

*significant; ns, not significant*.

Randomized quantile residuals analysis (Dunn and Smyth, [@B2]; Spyroglou et al., [@B11]) revealed that the logistic regression model is suitable for MDD patient classification. Furthermore, the Anderson- Darling test was performed with *A* = 0.23 and *P* = 0.77.

This clinical study had 20 participants, which was a small sample size compared with large scale clinical studies. Therefore, we adopted LOOCV analysis, which was appropriate for accurately estimating small datasets (Yao et al., [@B16]). The logit score could potentially be used as an index of depression or mental health severity because it indicates a positive correlation with the SDS score that was used to screen for MDD (Shinba, [@B10]). The center of gravity for the logit score for the healthy volunteers was greater than that for the patients with MDD by about 120.

Discussion {#s5}
==========

The high rate of suicidal intentions associated with increasing numbers of patients with MDD motivated us to develop a self-monitoring system for MDD screening. Conventionally, MDD is diagnosed by subjective methods such as self-report screening questionnaires or psychiatrist interviews based on Diagnostic and Statistical Manual of Mental Disorders V (DSM-V) published by American Psychiatric Association. Our previous study (Sun et al., [@B13]) adopted mental task induced autonomic response determined by ECG-derived HRV for MDD screening. The ECG-derived HRV based method achieved 80% sensitivity and 79% specificity via 91 subjects\' (44 patients with MDD and 47 normal volunteers) HRV dataset. However, ECG measurement is not applicable at home, school and workplaces and needs assistance of health-care professionals because it requires silver electrodes to be attached to body surface in order to reduce skin resistance. Therefore, comfort enhanced and user-friendly self-monitoring system for MDD screening is proposed in this paper. The system described here adopts a fingertip PPG sensor, which has several advantages over the initial ECG system that we previously described (Sun et al., [@B13]).

Proposed fingertip PPG sensor-based MDD screening system adopting multiple logistic regression model with LOOCV achieved 83% sensitivity and 93% specificity in distinguishing 6 patients with MDD from 14 healthy volunteers. In addition, the system appears promising not only for MDD screening but also for determining MDD severity levels.

The limitation of present study is that we tested the system with a rather small sample size of patients and healthy volunteers. Therefore, further study should involve more participants and be carried out to compare screening accuracy of MDD patients with and without anti-depressant medication. Moreover, it would be important to compare system sensitivity and specificity with those of recent MDD assessment tools such as Self-Rating Depression Scale (SDS), Hamilton Rating Scale for Depression (HAMD), Geriatric Depression Scale (GDS), and Beck Depression Inventory (BDI) for system accuracy investigation.

The preliminary results in this paper indicate our system to be a promising device for automated self-screening of people who potentially have MDD, either at home or at offices and without help of medical personnel.
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